Hyperpigmentation of the tongue, palms and soles: Rare side effect of capecitabine
Journal Title: Journal of Cancer Research & Therapy - Year 2013, Vol 1, Issue 10
Abstract
Cutaneous side effects of capecitabine include hand foot syndrome which manifests as erythema, swelling and/or desquamation. We report a case on capecitabine treatment presenting with unusual hyperpigmentation of the tongue and skin of the palms and soles. This is a rare manifestation of capecitabine toxicity in darker skin patients. Clinicians and health care workers in oncology should be aware of this potential side effect.
Authors and Affiliations
Zekri J, Abdel-Ghany EM
Keywords
Related Articles
- EP ID EP551867
- DOI 10.14312/2052-4994.2013-34
- Views 67
- Downloads 0
Evaluation of serum big endothelin-1 for the diagnosis and prediction of disease recurrence in breast cancer patients
Big endothelin-1 (big ET-1) is the biological precursor of endothelin-1 (ET-1) and it is known as an indicator for the degree of activation of endothelin system. Therefore, this study was designed to investigate the seru...
The first American cancer patient to receive dicycloplatin chemotherapy: A case report
Dicycloplatin (DCP), an effective platinum drug, was developed in China and approved by Chinese FDA in 2012. Its side effects are more bearable than those of cisplatin and carboplatin. The bladder cancer patient presente...
A clinical study on stereotactic body radiotherapy for hepatocellular carcinoma with portal vein tumor thrombosis
Purposes: Hepatocellular carcinoma with portal vein tumor thrombosis (HCC-PVTT) has a poor prognosis, while the optimal treatment remains controversial. The objective of this retrospective study was to evaluate the effic...
Can vascular endothelial growth factor C expression be of use in predicting surgical stage or prognosis in vulvar cancer ?
Introduction: Nodal metastasis is a main prognostic factor in vulvar cancer. Increased vascular endothelial growth factor C (VEGF-C) expression has been associated with lymph node metastasis and poor prognosis in many ca...
Colitis and chronic bleeding in patients treated with dasatinib
Dasatinib is a key therapeutic option in patients with chronic myeloid leukemia. Previous case reports associated it with acute colitis. This is another report that demonstrates a link between dasatinib and chronic colit...